ANI-guided Intraoperative Analgesia vs Conventional Intraoperative Analgesia

September 15, 2022 updated by: Hee-Soo Kim, Seoul National University Hospital

Effects of Analgesia Nociception Index (ANI)-Guided Intraoperative Analgesia on Postoperative Pain: a Randomized Controlled Study

This study evaluates the effects of Analgesia Nociception Index (ANI)-guided intraoperative analgesia on postoperative pain in patients undergoing open gynecologic surgery.

Study Overview

Detailed Description

Postoperative pain is one of the most common postoperative complications and is significantly associated with patient's quality of recovery. Analgesia Nociception Index (ANI) is known to analyze the high frequency component of heart rate variability in relation to respiratory frequency, providing the objective information on the degree of pain. However, most previous studies conducted by using ANI were observational studies or small-sized randomized controlled studies. In the present study, the investigators aimed to evaluate the effects of ANI-guided intraoperative analgesia on moderate-to-severe postoperative pain by performing randomized controlled study.

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 18
  • Elective open gynecological surgery
  • American Society of Anaesthesiologists physical status classification 1-3

Exclusion Criteria:

  • Laparoscopic surgery or robot-assisted surgery
  • Patients who had analgesic agents, anti-psychotic agents, anticonvulsants which were related to chronic pain
  • Patients who had hypersensitivity to analgesic agents or medications related anesthesia.
  • Patients who were required to have mechanical ventilation after surgery
  • Patients who had arrhythmia
  • Patients who transferred to the surgical intensive care unit immediately after surgery
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: ANI-guided intraoperative analgesia
Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil to maintain 50-70 of ANI index.
Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil to maintain 50-70 of ANI.
ACTIVE_COMPARATOR: Conventional intraoperative analgesia
Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil at the discretion of attending anesthesiologists based on hemodynamic parameters.
Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil at the discretion of attending anesthesiologists based on hemodynamic parameters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the incidence of moderate-to-severe postoperative pain
Time Frame: during 1 hour of stay in the postanesthesia care unit
the incidence of moderate-to-severe postoperative pain is defined as a case in which pain with numeric rating scale (NRS) of 5 or more is reported during stays in the postanesthesia care unit. Pain assessment is performed two times during stays in the postanesthesia care unit.
during 1 hour of stay in the postanesthesia care unit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the amount of intraoperative remifentanil
Time Frame: intraoperative
the amount of intraoperative remifentanil used during anesthesia
intraoperative
Quality of Recovery-15 (QoR-15) score
Time Frame: at postoperative 24 hour
QoR-15 questionnaire is recorded by an investigator. QoR-15 questionnaire has minimum score of 0 and maximum score of 150, and higher score indicates the better quality of recovery.
at postoperative 24 hour
the incidence of postoperative nausea and vomiting
Time Frame: at postoperative 1 hour, 24 hour, 72 hour
the incidence of postoperative nausea and vomiting is recorded by an investigator
at postoperative 1 hour, 24 hour, 72 hour
11-pointed NRS pain score
Time Frame: at postoperative 24 hour
11-pointed NRS pain score is measured at both resting state and movement. 11-pointed NRS pain score has minimum score of 0 and maximum score of 10, and higher score indicates the higher severity of pain.
at postoperative 24 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2021

Primary Completion (ACTUAL)

July 11, 2022

Study Completion (ACTUAL)

July 15, 2022

Study Registration Dates

First Submitted

April 30, 2021

First Submitted That Met QC Criteria

May 5, 2021

First Posted (ACTUAL)

May 7, 2021

Study Record Updates

Last Update Posted (ACTUAL)

September 19, 2022

Last Update Submitted That Met QC Criteria

September 15, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2104-033-1209

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on ANI-guided intraoperative analgesia

3
Subscribe